Shenfushu granules attenuate diabetic kidney disease by inhibiting PIK3R1/protein kinase B/heparanase-mediated endothelial-mesenchymal transition

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-1)

Sum=19

May 15, 2025 (publication date) through Apr 25, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. May 15, 2025; 16(5): 102196
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.102196

Table 1 Main characteristics of the animals

Src: Serum creatinine; BUN: Blood urea nitrogen; ACR: Albumin/urine creatinine ratio; SFSGs: Shenfushu granules.

Citation: Yang XD, Ma SJ, Xiang DX, Yang YY. Shenfushu granules attenuate diabetic kidney disease by inhibiting PIK3R1/protein kinase B/heparanase-mediated endothelial-mesenchymal transition. World J Diabetes 2025; 16(5): 102196
URL: https://www.wjgnet.com/1948-9358/full/v16/i5/102196.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i5.102196